Integrated Diagnostics (LON:IDHC) Hits New 1-Year High – Should You Buy?

Integrated Diagnostics Holdings plc (LON:IDHCGet Free Report) reached a new 52-week high on Monday . The stock traded as high as GBX 0.83 and last traded at GBX 0.79, with a volume of 140608 shares changing hands. The stock had previously closed at GBX 0.76.

Integrated Diagnostics Stock Up 3.9%

The company has a quick ratio of 0.75, a current ratio of 1.59 and a debt-to-equity ratio of 45.72. The stock has a market cap of £4.59 million, a P/E ratio of 0.00, a P/E/G ratio of 7.65 and a beta of 0.59. The company’s 50 day moving average price is GBX 0.67 and its two-hundred day moving average price is GBX 0.53.

About Integrated Diagnostics

(Get Free Report)

IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group’s core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company
a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests.

Read More

Receive News & Ratings for Integrated Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.